SANDIMMUNE

This brand name is authorized in Canada, Estonia, Netherlands, United States

Active ingredients

The drug SANDIMMUNE contains one active pharmaceutical ingredient (API):

1 Ciclosporin UNII 83HN0GTJ6D - CYCLOSPORINE

Ciclosporin (also known as ciclosporin A) is a cyclic polypeptide immunomodulator with immunosuppressant properties. It has been shown to prolong survival of allogeneic transplants in animals and significantly improved graft survival in all types of solid organ transplantation in man. Ciclosporin has also been shown to have an anti-inflammatory effect. Read about Ciclosporin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
SANDIMMUNE Capsule, Oral solution, Solution for injection	FDA, National Drug Code (US)	MPI, US: SPL/Old

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
L04AD01	Ciclosporin	L Antineoplastic and immunomodulating agents → L04 Immunosuppressants → L04A Immunosuppressants → L04AD Calcineurin inhibitors
Discover more medicines within L04AD01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 00593257
Country: EE	Ravimiamet	Identifier(s): 1172955
Country: NL	Z-Index G-Standaard	Identifier(s): 14084562
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 20346
Country: US	FDA, National Drug Code	Identifier(s): 0078-0109, 0078-0110, 0078-0240, 0078-0241